NasdaqGS:MEDPLife Sciences
Why Medpace Holdings (MEDP) Is Up 52.8% After Q2 Beat and Share Buyback and What's Next
Medpace Holdings recently reported its second quarter 2025 financial results, posting US$603.31 million in sales and US$90.26 million net income, along with updated full-year guidance projecting revenues between US$2.42 billion and US$2.52 billion.
The company also completed a significant share repurchase program, reducing its shares outstanding by nearly 15%, which may increase shareholder value through a higher earnings per share.
We'll explore how Medpace's robust quarterly growth and...